QURE logo

uniQure NV (QURE)

Profile

Full Name

uniQure N.V.

Ticker Symbol

QURE

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

Netherlands

IPO

February 5, 2014

Indexes

Not included

Website

http://www.uniqure.com

Employees

209

Key Details

Price

$11.50

Market Cap

$621.88M(Small cap)

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$27.12M(+71.17% YoY)

Annual EPS

-$4.92(+23.96% YoY)

PE Ratio

-

Next earnings date

May 7, 2025

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

$11.50
QURE price is $11.50

Price All-time High

$82.19
QURE price is currently -86.01% below its historical high of $82.19

Price Today Change

-8%
QURE price is down -8% today

Price YTD Change

-35.03%
QURE price is down -35.03% since January 1st

Price 1-year Change

+119.05%
QURE price is up +119.05% year-on-year

Price 3-year Change

-36.36%
QURE price is down -36.36% over the past 3 years

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market Cap

$621.88M
QURE market capitalization is $621.88 million

Market Cap 3-year Change

-26.21%
QURE market capitalization is down -26.21% over the past 3 years

Market Cap All-time High

$3.25B
QURE market capitalization is currently -80.89% below its historical high of $3.25 billion

Market Cap Sector Rank

71.24%
QURE market capitalization is higher than 71.24% of companies in Healthcare sector

Shares Outstanding

Shares Outstanding 1-Year Change

+13.04%
QURE shares outstanding is up +13.04% year-on-year

Shares Outstanding 3-Year Change

+16.4%
QURE shares outstanding is up +16.4% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

2.10
QURE beta is 2.10

200-day SMA

$9.31
QURE price is currently +23.56% above its 200-day simple moving average

50-day SMA

$13.77
QURE price is currently -16.46% below its 50-day simple moving average

RSI

44.07
QURE 14-day relative strength index is 44.07

Volume

0.98
QURE 30-day relative volume is 0.98

ATR

$1.10
QURE average true range is $1.10

10-day Historical Volatility

79.95%
QURE 10-day historical volatility is 79.95%

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

$27.12M
QURE annual revenue is $27.12 million

Revenue Analysts Estimate

$39.54M
QURE annual revenue is currently -31.42% lower than the consensus analysts' forecast

Revenue 1-year Change

+71.17%
QURE annual revenue is up +71.17% year-on-year

Revenue Sector Rank

37.56%
QURE annual revenue is higher than 37.56% of companies in Healthcare sector

EPS

EPS

-$4.92
QURE annual earnings per share is -$4.92

EPS Analysts Estimate

-$3.72
QURE annual earnings per share is currently +32.12% higher than the consensus analysts' forecast

EPS 1-year Change

+23.96%
QURE annual earnings per share is up +23.96% year-on-year

EPS Sector Rank

20.08%
QURE annual earnings per share is higher than 20.08% of companies in Healthcare sector

Profit

Gross Profit

$8.79M
QURE annual gross profit is $8.79 million

Gross Margin

32.42%
QURE annual gross profit margin is 32.42%

Operating Profit

-$180.93M
QURE annual operating income is -$180.93 million

Operating Margin

-667.17%
QURE annual operating profit margin is -667.17%

Net Income

-$239.56M
QURE annual net profit is -$239.56 million

Net Margin

-883.35%
QURE annual net profit margin is -883.35%

Expenses

Total Expenses

$208.05M
QURE annual total expenses is $208.05 million

Operating Expenses

$189.72M
QURE annual total operating expenses is $189.72 million

Cost Of Goods Sold

$18.33M
QURE annual cost of goods sold is $18.33 million

Selling, General & Administrative Expenses

$50.68M
QURE annual SGA is $50.68 million

Depreciation And Amortization

$12.64M
QURE annual depreciation & amortization is $12.64 million

Interest Expense

$63.74M
QURE annual interest expense is $63.74 million

Income Tax

$2.43M
QURE annual income tax is $2.43 million

EBIT & EBITDA

EBIT

-$173.39M
QURE annual earnings before interest & taxes is -$173.39 million

EBITDA

-$160.75M
QURE annual EBITDA is -$160.75 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total Assets

$556.54M
QURE annual total assets is $556.54 million

Non Current Assets

$166.25M
QURE annual long term assets is $166.25 million

Current Assets

$390.29M
QURE annual total current assets is $390.29 million

Cash And Cash Equivalents

$158.93M
QURE annual cash & cash equivalents is $158.93 million

Accounts Receivable

$5.88M
QURE annual accounts receivable is $5.88 million

Inventory

$0.00
QURE annual inventory is $0.00

Liabilities

Total Liabilities

$563.29M
QURE annual total liabilities is $563.29 million

Long Term Liabilities

$523.24M
QURE annual total long term liabilities is $523.24 million

Current Liabilities

$40.05M
QURE annual total current liabilities is $40.05 million

Accounts Payable

$7.23M
QURE annual accounts payable is $7.23 million

Debt

Total Debt

$66.06M
QURE annual total debt is $66.06 million

Total Debt 1-year Change

-52.27%
QURE annual total debt is down -52.27% year-on-year

Long Term Debt

$62.46M
QURE annual long term debt is $62.46 million

Short Term Debt

$3.60M
QURE annual short term debt is $3.60 million

Equity & Capital

Shareholders Equity

-$6.75M
QURE annual stockholders equity is -$6.75 million

Book Value

-$6.75M
QURE annual book value is -$6.75 million

Retained Earnings

-$1.13B
QURE annual retained earnings is -$1.13 billion

Working Capital

$350.24M
QURE annual working capital is $350.24 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash From Operations

-$182.73M
QURE annual cash flow from operations is -$182.73 million

Cash From Operations 1-year Change

-25.22%
QURE annual cash flow from operations is down -25.22% year-on-year

Cash From Investing

$162.97M
QURE annual cash flow from investing activities is $162.97 million

Cash From Investing 1-year Change

+179.23%
QURE annual cash flow from investing activities is up +179.23% year-on-year

Cash From Financing

-$59.49M
QURE annual cash flow from financing activities is -$59.49 million

Cash From Financing 1-year Change

-116.4%
QURE annual cash flow from financing activities is down -116.4% year-on-year

CAPEX

CAPEX

$11.69M
QURE annual capital expenditures is $11.69 million

CAPEX 1-year Change

+63.39%
QURE annual capital expenditures is up +63.39% year-on-year

Free Cash Flow

Free Cash Flow

-$194.42M
QURE annual free cash flow is -$194.42 million

Free Cash Flow 1-year Change

-27%
QURE annual free cash flow is down -27% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross Margin

32.42%
QURE annual gross profit margin is 32.42%

Operating Margin

-667.17%
QURE annual operating profit margin is -667.17%

Net Margin

-883.35%
QURE annual net profit margin is -883.35%

ROA & ROE

ROA

-34.51%
QURE annual return on assets is -34.51%

ROE

-238.46%
QURE annual return on equity is -238.46%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE Ratio

-
QURE price to earnings ratio value is unknown

PE Ratio Sector Rank

-
QURE price to earnings ratio is unknown

PB Ratio

PB Ratio

-92.10
QURE price to book ratio is -92.10

PB Ratio Sector Rank

0.41%
QURE price to book ratio is higher than 0.41% of companies in Healthcare sector

PS Ratio

PS Ratio

22.93
QURE price to sales ratio is 22.93

PS Ratio Sector Rank

87.4%
QURE price to sales ratio is higher than 87.4% of companies in Healthcare sector

Enterprise value

Enterprise Value

$529.02M
QURE enterprise value is $529.02 million

Enterprise Value Sector Rank

69.32%
QURE enterprise value is higher than 69.32% of companies in Healthcare sector

EV/EBITDA

EV/EBITDA

-3.29
QURE EV/EBITDA is -3.29

EV/EBITDA Sector Rank

27.27%
QURE EV/EBITDA is higher than 27.27% of companies in Healthcare sector

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current Ratio

9.74
QURE annual current ratio is 9.74

Quick Ratio

9.74
QURE annual quick ratio is 9.74

Leverage

Debt To Equity

-7.60
QURE annual debt to equity ratio is -7.60

Interest Coverage Ratio

-2.72
QURE annual interest coverage ratio is -2.72

Risk & Stability

Piotroski F-Score

5
QURE piotroski f-score is 5

Altman Z-Score

-2.40
QURE altman z-score is -2.40

Analyst ratings

Recent major analysts updates

Mar 4, 25 HC Wainwright & Co.
Buy
Feb 28, 25 Wells Fargo
Equal-Weight
Jan 27, 25 HC Wainwright & Co.
Buy
Jan 21, 25 RBC Capital
Outperform
Dec 19, 24 Mizuho
Neutral
Dec 16, 24 Stifel
Buy
Dec 12, 24 Goldman Sachs
Neutral
Dec 11, 24 RBC Capital
Outperform
Dec 11, 24 Leerink Partners
Outperform
Dec 11, 24 Guggenheim
Buy

Institutional Ownership

Similar stocks

PRTA logo
Prothena (PRTA)
IRMD logo
IRadimed (IRMD)
CVAC logo
CureVac NV (CVAC)
ABCL logo
AbCellera Biologics (ABCL)
GHRS logo
GH Research (GHRS)
CRON logo
Cronos (CRON)
ABUS logo
Arbutus Biopharma (ABUS)
OMI logo
Owens & Minor (OMI)
AVBP logo
ArriVent BioPharma (AVBP)
  • What is the ticker symbol for uniQure NV?
  • Does uniQure NV pay dividends?
  • What sector is uniQure NV in?
  • What industry is uniQure NV in?
  • What country is uniQure NV based in?
  • When did uniQure NV go public?
  • Is uniQure NV in the S&P 500?
  • Is uniQure NV in the NASDAQ 100?
  • Is uniQure NV in the Dow Jones?
  • When was uniQure NV's last earnings report?
  • When does uniQure NV report earnings?
  • Should I buy uniQure NV stock now?

What is the ticker symbol for uniQure NV?

The ticker symbol for uniQure NV is NASDAQ:QURE

Does uniQure NV pay dividends?

No, uniQure NV does not pay dividends

What sector is uniQure NV in?

uniQure NV is in the Healthcare sector

What industry is uniQure NV in?

uniQure NV is in the Biotechnology industry

What country is uniQure NV based in?

uniQure NV is headquartered in Netherlands

When did uniQure NV go public?

uniQure NV's initial public offering (IPO) was on February 5, 2014

Is uniQure NV in the S&P 500?

No, uniQure NV is not included in the S&P 500 index

Is uniQure NV in the NASDAQ 100?

No, uniQure NV is not included in the NASDAQ 100 index

Is uniQure NV in the Dow Jones?

No, uniQure NV is not included in the Dow Jones index

When was uniQure NV's last earnings report?

uniQure NV's most recent earnings report was on Feb 27, 2025

When does uniQure NV report earnings?

The next expected earnings date for uniQure NV is May 7, 2025

Should I buy uniQure NV stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page